semaglutide medicine US FDA approves weight loss drug Wegovy to prevent cardiovascular events Why weight-loss drugs became more

No lab work is required for eligibility

The medication helps the pancreas release insulin when blood glucose levels rise, reduces the amount of sugar released by the liver, and slows down how quickly food leaves the stomach, though some patients may experience constipation or, in rare cases, pancreatitis

Compared with metformin (the first-line treatment for most patients), GLP-1 receptor agonists generally produce similar or slightly greater HbA1c reductions but with the added benefit of weight loss rather than weight neutrality

An initial report showed mice treated with 1 g/kg of vitamin E had an increased in the lethal radiation dose (LD50)

this finding was almost driven by the association between HbA1c reduction and non-fatal stroke

For travel, keep in a 4C cooler bag this preserves viscosity and prevents phase separation